Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

Published Date: 08 Jul 2024

Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Which women need more than mammograms for breast cancer screening?

2.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

3.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

4.

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

5.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot